Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy and safety of Peginterferón alfa-2a (40 KD) plus Ribavirin in
patients who have relapsed or not responded to a previous suboptimal therapy based in
Interferon.